Logo image of GLRE

GREENLIGHT CAPITAL RE LTD-A (GLRE) Stock Fundamental Analysis

NASDAQ:GLRE - Nasdaq - KYG4095J1094 - Common Stock - Currency: USD

13.18  -0.27 (-2.01%)

Fundamental Rating

3

Taking everything into account, GLRE scores 3 out of 10 in our fundamental rating. GLRE was compared to 143 industry peers in the Insurance industry. GLRE may be in some trouble as it scores bad on both profitability and health. GLRE has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

GLRE had positive earnings in the past year.
In the past year GLRE had a positive cash flow from operations.
GLRE had positive earnings in 4 of the past 5 years.
In multiple years GLRE reported negative operating cash flow during the last 5 years.
GLRE Yearly Net Income VS EBIT VS OCF VS FCFGLRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

GLRE's Return On Assets of 2.12% is in line compared to the rest of the industry. GLRE outperforms 48.95% of its industry peers.
Looking at the Return On Equity, with a value of 6.73%, GLRE is doing worse than 65.03% of the companies in the same industry.
Industry RankSector Rank
ROA 2.12%
ROE 6.73%
ROIC N/A
ROA(3y)2.61%
ROA(5y)1.57%
ROE(3y)7.77%
ROE(5y)4.66%
ROIC(3y)N/A
ROIC(5y)N/A
GLRE Yearly ROA, ROE, ROICGLRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Profit Margin of GLRE (6.54%) is comparable to the rest of the industry.
GLRE's Profit Margin has improved in the last couple of years.
GLRE's Operating Margin of 1.75% is on the low side compared to the rest of the industry. GLRE is outperformed by 81.12% of its industry peers.
In the last couple of years the Operating Margin of GLRE has grown nicely.
Industry RankSector Rank
OM 1.75%
PM (TTM) 6.54%
GM N/A
OM growth 3Y82.31%
OM growth 5YN/A
PM growth 3Y158.28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLRE Yearly Profit, Operating, Gross MarginsGLRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

3

2. Health

2.1 Basic Checks

GLRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
GLRE has less shares outstanding than it did 1 year ago.
The number of shares outstanding for GLRE has been reduced compared to 5 years ago.
The debt/assets ratio for GLRE has been reduced compared to a year ago.
GLRE Yearly Shares OutstandingGLRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
GLRE Yearly Total Debt VS Total AssetsGLRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

GLRE has a debt to FCF ratio of 8.09. This is a slightly negative value and a sign of low solvency as GLRE would need 8.09 years to pay back of all of its debts.
GLRE has a worse Debt to FCF ratio (8.09) than 70.63% of its industry peers.
GLRE has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
GLRE has a better Debt to Equity ratio (0.10) than 80.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 8.09
Altman-Z N/A
ROIC/WACCN/A
WACC8.45%
GLRE Yearly LT Debt VS Equity VS FCFGLRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
GLRE Yearly Current Assets VS Current LiabilitesGLRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for GLRE have decreased strongly by -49.16% in the last year.
Measured over the past years, GLRE shows a very strong growth in Earnings Per Share. The EPS has been growing by 34.26% on average per year.
GLRE shows a small growth in Revenue. In the last year, the Revenue has grown by 7.29%.
EPS 1Y (TTM)-49.16%
EPS 3Y34.26%
EPS 5YN/A
EPS Q2Q%-262%
Revenue 1Y (TTM)7.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.63%

3.2 Future

GLRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.14% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y34.88%
EPS Next 2Y16.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLRE Yearly Revenue VS EstimatesGLRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
GLRE Yearly EPS VS EstimatesGLRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6 -8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.89 indicates a reasonable valuation of GLRE.
GLRE's Price/Earnings ratio is a bit cheaper when compared to the industry. GLRE is cheaper than 60.84% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.29. GLRE is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 8.08, the valuation of GLRE can be described as reasonable.
Based on the Price/Forward Earnings ratio, GLRE is valued a bit cheaper than the industry average as 71.33% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.32. GLRE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.89
Fwd PE 8.08
GLRE Price Earnings VS Forward Price EarningsGLRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

67.13% of the companies in the same industry are cheaper than GLRE, based on the Enterprise Value to EBITDA ratio.
GLRE's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. GLRE is more expensive than 73.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 60.68
EV/EBITDA 40.14
GLRE Per share dataGLRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GLRE's earnings are expected to grow with 16.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y16.14%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GLRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENLIGHT CAPITAL RE LTD-A

NASDAQ:GLRE (4/21/2025, 1:47:29 PM)

13.18

-0.27 (-2.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)03-10 2025-03-10/amc
Earnings (Next)05-13 2025-05-13
Inst Owners50.48%
Inst Owner Change0.01%
Ins Owners23.98%
Ins Owner Change0.02%
Market Cap455.50M
Analysts43.33
Price TargetN/A
Short Float %0.82%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1909.13%
Min EPS beat(2)-3870.59%
Max EPS beat(2)52.34%
EPS beat(4)1
Avg EPS beat(4)-958.12%
Min EPS beat(4)-3870.59%
Max EPS beat(4)52.34%
EPS beat(8)5
Avg EPS beat(8)-410.68%
EPS beat(12)6
Avg EPS beat(12)-387.55%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.89
Fwd PE 8.08
P/S 0.7
P/FCF 60.68
P/OCF 60.68
P/B 0.72
P/tB 0.72
EV/EBITDA 40.14
EPS(TTM)1.21
EY9.18%
EPS(NY)1.63
Fwd EY12.38%
FCF(TTM)0.22
FCFY1.65%
OCF(TTM)0.22
OCFY1.65%
SpS18.95
BVpS18.4
TBVpS18.4
PEG (NY)0.31
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.12%
ROE 6.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 1.75%
PM (TTM) 6.54%
GM N/A
FCFM 1.15%
ROA(3y)2.61%
ROA(5y)1.57%
ROE(3y)7.77%
ROE(5y)4.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y82.31%
OM growth 5YN/A
PM growth 3Y158.28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 8.09
Debt/EBITDA 5.29
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.24
Cash Conversion 65.38%
Profit Quality 17.53%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.16%
EPS 3Y34.26%
EPS 5YN/A
EPS Q2Q%-262%
EPS Next Y34.88%
EPS Next 2Y16.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-74.94%
EBIT growth 3Y98.58%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y123.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y123.61%
OCF growth 3YN/A
OCF growth 5YN/A